|3.97||+0.11 / +2.85%|
Data as of 4:00pm ET
|3.97||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +101.51% increase from the last price of 3.97.
The current consensus among 4 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.